Brief: Synplogen And Ginkgo Bioworks Announce Plans To Accelerate Global Dna Manufacturing And Gene Therapy Platform Services In Japan
Dec 6 (Reuters) - Ginkgo Bioworks Holdings Inc DNA.N :
* SYNPLOGEN AND GINKGO BIOWORKS ANNOUNCE PLANS TO ACCELERATE
GLOBAL DNA MANUFACTURING AND GENE THERAPY PLATFORM SERVICES IN
JAPAN
* SYNPLOGEN CO - INTENDS TO SUPPORT AND INTRODUCE GINKGO'S
GENE
THERAPY SERVICES WITHIN JAPANESE BIOTECHNOLOGY AND
PHARMACEUTICAL ECOSYSTEM
Source text for Eikon: ID:nPn3WFg75a
Further company coverage: DNA.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ginkgo Bioworks Holdings
See all newsUS STOCKS ON THE MOVE-NiSource, Hewlett Packard, Sandisk
US STOCKS ON THE MOVE-CoreWeave, Moderna, Fox Corp
Brief: Ginkgo Bioworks To Provide Autonomous Lab Access To Nsf X-Labs Researchers
US weighs allowing most pharma licensing deals with China, sources say
Ginkgo Bioworks Holdings, Inc. reports results for the quarter ended June 30 - Earnings Summary